Qynapse
Paris
About Qynapse
Qynapse is on a mission to advance the accuracy and reliability of Central Nervous System (CNS) diseases screening and monitoring in both clinical routine settings and in clinical trial applications. We combine MRI scans and AI to produce rapid, actionable insights.The company is headquartered in France, in the United States and in Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.6M
- Funding stage: Seed
- Last round: Seed (Jun 2021)
- Website: qynapse.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Clinical Trials, Health Care, Information Technology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/qynapse-91283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.